Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02493491 · ClinicalTrials.gov registry record
Neurogenic Dysphonia/Dysphagia Registry
A clinical trial, sponsored by Merz North America.
- Terminated
- Registry status
- 146
- Enrollment target
NCT02493491: Clinical Trial study, sponsored by Merz North America.
NCT02493491 is a clinical trial that was terminated before completion, run by Merz North America. The registered enrollment target is 146 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02493491 was terminated before completion, sponsored by Merz North America.
- TERMINATED
- Registry status
- 146 participants
- Enrollment target
Study Summary
The Neurogenic Dysphonia/Dysphagia Registry is designed to be purely observational (i.e. non-interventional, exploratory). Patient data collected from the registry is expected to be consistent with any information which can be obtained during usual care of patients with dysphonia/dysphagia treated with vocal fold augmentation.
Primary Outcome
Characterize the initial assessment (e.g. types of assessments/evaluations performed and severity of voice, swallowing, cough as determined by patient reported outcomes where available)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 146 participants |
| Start Date | 2015-06 |
| Est. Completion | 2016-09 |
Why NCT02493491 stopped before completion
NCT02493491 is an observational study that tracks outcomes without assigning an intervention. The registered 146 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT02493491 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02493491 about?
NCT02493491 is a clinical study titled "Neurogenic Dysphonia/Dysphagia Registry". The Neurogenic Dysphonia/Dysphagia Registry is designed to be purely observational (i.e. non-interventional, exploratory). Patient data collected from the registry is expected to be consistent with any information which can be obtained during usual care of patients with dysphonia/dysphagia treated w...
What is the current status of trial NCT02493491?
This trial is currently terminated. The enrollment target is 146 participants. The study started on 2015-06. Estimated completion is 2016-09.
Who is sponsoring clinical trial NCT02493491?
This trial is sponsored by Merz North America, which has 35 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03490929 · 146 participants · Phase 4
CEUS for Blunt Abdominal Trauma in Children
- NCT04755062 · 146 participants · NA
A Culturally-relevant Micronutrient-dense Plant-rich (mNDPR) Dietary Intervention for Native Americans
- NCT04867954 · 146 participants
Development of 4D Flow MRI for Risk Stratification of Variceal Bleeding in Cirrhosis
- NCT05051618 · 146 participants · NA
Exercise Training for Managing Major Depressive Disorder in Multiple Sclerosis
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia